NaturalShrimp, responsible for patenting the first shrimp-focused, commercially operational recirculating aquaculture system (RAS) announced recently the results of its study, which took place at the Marineholmen RASLab in Norway. The study was carried out to evaluate the impact of hyper-antioxidant technologies on oxidation and fish health in RAS.
Their technologies, named Hydrogas™ and RLS™, are designed to eliminate the problems caused by oxidation, to reduce the redox reaction in fish gills and prevent fish falling ill to ammonia. NaturalShrimp's research was funded through its market development partnership with Hydrenesis, Inc. In August this year, NaturalShrimp acquired Hydrenesis' aquaculture assets.
'An initial trial was performed with RASLab (Norway) to investigate the effects of negative ORP environment on Atlantic salmon smolt,' Christine Huynh, DVM aquatic species consultant for Natural Shrimp, explained. 'Fish grown in Hydrogas had significantly improved welfare scores, fewer inflammatory gill lesions and reduced early maturation. These early results are promising, and our intention is to explore the production, health, and welfare effects further. The technology could potentially enhance the welfare and condition of Atlantic salmon in RAS.'
The focus of the study is on freshwater salmon production and if successful, could enable Natural Shrimp to enter into markets including salmon, barramundi, and other freshwater fish.
Tom Untermeyer, the CTO and COO of NaturalShrimp, concluded, 'We continue to witness the positive effects of using the HydroGas technology for a variety of aquaculture applications. The positive result from this trial further substantiates our previous observations. We expect that the HydroGas technology, along with our patented Electrocoagulation (EC) technology, will provide solutions to many problems that have existed within the aquaculture communities.'
To find out more information, visit NaturalShrimp's website, HERE.
No comments:
Post a Comment